Literature DB >> 29110212

Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy.

Susan G Dorsey1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29110212      PMCID： PMC5794697          DOI： 10.1007/s13311-017-0584-1

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  18 in total

Review 1.  The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.

Authors:  Tsung-Ping Su; Tzu-Chieh Su; Yoki Nakamura; Shang-Yi Tsai
Journal:  Trends Pharmacol Sci       Date:  2016-02-09       Impact factor: 14.819

Review 2.  Investigational sigma-1 receptor antagonists for the treatment of pain.

Authors:  José Miguel Vela; Manuel Merlos; Carmen Almansa
Journal:  Expert Opin Investig Drugs       Date:  2015-06-03       Impact factor: 6.206

3.  Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

Authors:  Ellen M Lavoie Smith; Herbert Pang; Constance Cirrincione; Stewart Fleishman; Electra D Paskett; Tim Ahles; Linda R Bressler; Camilo E Fadul; Chetaye Knox; Nguyet Le-Lindqwister; Paul B Gilman; Charles L Shapiro
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

4.  Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.

Authors:  Kathleen A Griffith; Shijun Zhu; Meg Johantgen; Michael D Kessler; Cynthia Renn; Andreas S Beutler; Rahul Kanwar; Nicholas Ambulos; Guido Cavaletti; Jordi Bruna; Chiara Briani; Andreas A Argyriou; Haralabos P Kalofonos; Laura M Yerges-Armstrong; Susan G Dorsey
Journal:  J Pain Symptom Manage       Date:  2017-07-23       Impact factor: 3.612

Review 5.  Chemotherapy-induced peripheral neurotoxicity.

Authors:  Guido Cavaletti; Paola Marmiroli
Journal:  Curr Opin Neurol       Date:  2015-10       Impact factor: 5.710

Review 6.  Oxaliplatin-safety profile: neurotoxicity.

Authors:  Axel Grothey
Journal:  Semin Oncol       Date:  2003-08       Impact factor: 4.929

Review 7.  Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.

Authors:  Christian A von Hehn; Ralf Baron; Clifford J Woolf
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

8.  Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.

Authors:  Cynthia L Renn; Valentina A Carozzi; Peter Rhee; Danisha Gallop; Susan G Dorsey; Guido Cavaletti
Journal:  Mol Pain       Date:  2011-04-26       Impact factor: 3.395

9.  Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice.

Authors:  Francisco R Nieto; Cruz M Cendán; Francisco J Cañizares; María A Cubero; José M Vela; Eduardo Fernández-Segura; José M Baeyens
Journal:  Mol Pain       Date:  2014-02-11       Impact factor: 3.395

10.  Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.

Authors:  Bhavana Bhatnagar; Steven Gilmore; Olga Goloubeva; Colleen Pelser; Michelle Medeiros; Saranya Chumsri; Katherine Tkaczuk; Martin Edelman; Ting Bao
Journal:  Springerplus       Date:  2014-07-16
View more
  1 in total

Review 1.  Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms.

Authors:  Zifen Xu; Yushuang Lei; Huan Qin; Shiyao Zhang; Ping Li; Kai Yao
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.